|
|
 |
|
Viewing report
|
|
|
|
Epidemiology: Prostate Cancer
Datamonitor, March 2011, Pages: 34
Introduction
Over the forecast period, prostate cancer incident cases will increase in all of the seven major markets. These increases are most likely to be as a result of an aging population who are at risk of developing prostate cancer, and an increase in screening coverage.
Features and benefits
- Gain insight to market potential, including a robust 10-year epidemiology forecast of prostate cancer incident cases.
- Understand the key epidemiologic risk factors associated with prostate cancer.
Highlights
- It is estimated that in 2010, there will be approximately 516,000 newly diagnosed cases of prostate cancer in the seven major markets (US, Japan, France, Germany, Italy, Spain and the UK). Between 2010 and 2019, total prostate cancer incident cases in the seven major markets are forecasted to increase by 37% reflecting aging populations.
- In 2008, prostate cancer was the second most common cancer in men and the fifth most common cancer overall in the world. Three-quarters of all incident cases of prostate cancer occur in men aged 65 years and older.
Your key questions answered
- What are the most robust sources for prostate cancer incidence data?
- How will the patient population change over the next decade in the US, Japan, and five major EU markets (France, Germany, Italy, Spain, and the UK)?
- What are the major risk factors for prostate cancer that drive the trend in incident cases and how are they changing?
|
|
|
|
